0001209191-22-031994.txt : 20220525
0001209191-22-031994.hdr.sgml : 20220525
20220525195432
ACCESSION NUMBER: 0001209191-22-031994
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220524
FILED AS OF DATE: 20220525
DATE AS OF CHANGE: 20220525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pruzanski Mark
CENTRAL INDEX KEY: 0001559569
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38692
FILM NUMBER: 22964608
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES ST.
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Equillium, Inc.
CENTRAL INDEX KEY: 0001746466
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821554746
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 105
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 412-5302
MAIL ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 105
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-24
0
0001746466
Equillium, Inc.
EQ
0001559569
Pruzanski Mark
2223 AVENIDA DE LA PLAYA, SUITE 105
LA JOLLA
CA
92037
1
0
0
0
Stock Option (right to buy)
2.59
2022-05-24
4
A
0
20000
0.00
A
2032-05-24
Common Stock
20000
20000
D
The option vests in twelve equal monthly installments commencing on the grant date of May 24, 2022, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.
/s/ Jason A. Keyes, Attorney-in-Fact for Mark Pruzanski
2022-05-25